| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $0.32 | $0.28 | $0.27 | $0.26 | $0.29 | $0.30 | $0.29 | $0.31 |
| EPS (Diluted) | $0.32 | $0.28 | $0.26 | $0.26 | $0.29 | $0.29 | $0.28 | $0.30 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.5B | $17.1B | $16.9B | $15.8B | $14.1B | $14.6B | $14.5B | $14.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.5B | $0.5B | $0.4B | $0.5B | $0.5B | $0.3B | $0.3B |
| Total Liabilities | $15.6B | $15.2B | $15.0B | $13.9B | $12.3B | $13.0B | $12.8B | $12.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.9B | $1.9B | $1.9B | $1.8B | $1.7B | $1.7B | $1.7B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.4B | $-0.1B | $-1.0B | $-1.9B | $0.5B | $0.1B | $-0.3B | $-0.5B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.3B | $0.0B | $1.0B | $1.7B | $-0.6B | $-0.0B | $0.2B | $0.3B |